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Burden is an ancient biblical term, denoting a heavy load or
fate, that I found convenient to use as a title of a 1975 report
to encompass the findings of prevalence, morbidity,
disability, and social costs of dermatologic disease, in the
first US Health and Nutrition Examination Survey of 1971 to
1974 (HANES) (Johnson, 1978). In the advent of HANES,
because the impact of disease in the US population was
measured in terms of mortality, data derived from death
certificates, the importance of skin disease was considered
to be trivial. After HANES, to serve the information needs of
planners and payers for health services, assessments
began to include attendant morbidity and altered functional
status of patients, and the consumption of goods and
services for their care. Nevertheless, such assessments
have not been made on the basis of data gathered from
examination of a large representative sample of the US
population of ages 1 to 74, nor with the scientific or
epidemiologic rigor of HANES.
History of the Inclusion of a Dermatologic
Component in HANES
The opportunity to establish, for the first time, reliable and
scientifically valid estimates of the burden of skin disease in
the United States came to me in Hiroshima, Japan. There, in
1966 at the US National Academy of Sciences–Japanese
National Institute of Health Atomic Bomb Casualty Commis-
sion (ABCC), Arthur McDowell of the US National Center for
Health Statistics (NCHS) visited ABCC as a consultant and
gave a seminar on biostatistical and epidemiologic planning
and procedures of health examination surveys of the US
population that had been used in two prior NCHS surveys, a
third was in progress. Observations about the skin were not
included in the first two, and the third only noted the
presence or absence of acne and the number of nevi.
During his visit, Mr McDowell reviewed my first and
ongoing research in the epidemiology of skin cancer and
accelerated aging in a sample of 15,000 A-bomb survivors
and controls. He seemed amused to meet a dermatologist
who was performing an epidemiologic study and who was
as strict as he would be about its proper conduct. The latter
reflected the training and guidance I had received from
outstanding senior ABCC staff.
When he mentioned that the next health examination
survey was scheduled to begin in 1971, I urged him to
consider the great importance of including a comprehensive
skin examination, and we reviewed the technical and
logistic problems involved in realizing my request. Con-
vinced of the gain for dermatology of this undertaking, I
promised to be responsible for many things: the design and
testing of the examination forms and procedures, providing
an expanded ICD code, recruiting and training examiners
in an assessment of the extent and morbidity of skin
conditions to work at 65 field stations in the United States,
and securing pathology services for handling scrapings and
biopsies. It was clearly a study of such complexity and cost
that only the federal government could afford it.
I left Japan in 1967 to join Rudolf Baer, MD, chair of the
Department of Dermatology at NYU Skin and Cancer Unit at
the precise moment that the AAD’s Joint Committee on
Planning for Dermatology was beginning, with the urging
of Philip Anderson, MD, to plan its National Program for
Dermatology. I was selected as its secretary and chair of the
data collection unit.
Dr Baer, chair of the Joint Committee, shared my
excitement about the inclusion of a dermatologic compo-
nent in the next NCHS health examination survey. With the
strong and broad support of Drs Baer and Anderson; of the
President of the Academy, Clarence Livingood, MD; and of
all academic chairs of departments of dermatology and
their residents and with NYU’s diagnostic codes developed
by Alfred Kopf, MD, all of my grand promises to NCHS
could be met.
All 65 stations were staffed by over 100 dermatologists/
examiners, mainly senior dermatology residents who were
prepared for their assignment at annual meetings of the
Academy by David Ramsay, MD, and myself. The compre-
hensive screening examination demanded for HANES bore
only a slight resemblance to the usual encounter in the
dermatology clinic; so many observations and variations
had to be noted and recorded as well as diagnoses. Dr
Ramsay or I would meet with the examiners on site to
reinforce their training. The NYU Code of Skin Diseases
worked well. At the completion of the survey I had reviewed
representative samplings of the 20,637 examinations to
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ensure consistency with the examination protocol and
resolved the diagnoses of skin cancer and dermatophy-
toses on the basis of subsequent findings of biopsy and
laboratory determinations of fungus.
HANES Findings (1971–1974)
Skin pathology Nearly one-third (312.4 per 1000 popula-
tion), or an estimated 60 million of the US population age 1
to 74 y, had some skin pathology: one or more significant
conditions that called for evaluation by a physician.
The prevalence of significant skin pathology increased
rapidly with age from 14.2% at age 1 to 5 y to 36.5% at age
12 to 17 and 36.5% at age 18 to 24 (Fig 1). The prevalence
continues to increase with advancing age, reflecting
cumulative increases in such diagnoses as psoriasis and
vitiligo and the accelerated appearance of malignant and
benign tumors, as well as actinic and seborrheic keratoses.
Among the specific types of skin pathology, the most
prevalent were diseases of sebaceous glands, dermato-
phytoses, tumors (malignant and benign), seborrheic
dermatitis, atopic dermatitis/eczema, contact dermatitis,
and ichthyosis/keratosis (Fig 2).
Occupational exposure Nearly one-fourth (23.9%) of
adults 18 to 74 y of age with significant skin pathology
indicated exposure in the work place to chemicals, fumes,
vapors, oils, or insecticide or to prolonged immersion of the
hands and feet. Occupational exposure was twice as high
among men (32.4%) compared to women (14.4%); among
both sexes the rates drop off at age 65 to 74.
In addition to gathering data about normal variations and
the presence of benign lesions as well as pathology, one-
third of the examination form focused on specific diagnosis
and details about the atopic individual, the psoriatic, for
example. But of greater interest for a consideration of the
burden of the problem is that one-third of the form gathered
data about the impact of the dermatologic diagnosis on the
individual and his or her psyche as well as soma and how it
troubled him or her and interfered with function, livelihood,
and social interactions. We also asked the examiner to
weigh the handicap and, further, to assess the problem from
the standpoint of care. Was the patient receiving the best
care for that problem and if not, why not? Was the patient or
his physician unaware that there was helpful treatment—or
was the care too distant, the treatment too expensive?
Examinee’s concern There was also in this section a focus
on the examinee’s concern, their complaints, and their
perception of their problem. Some 11.8% or an estimated
22.9 million of the US population 1 to 74 y of age had one or
more conditions about which they complained or expressed
concern. Most (96%) complained about a specific condition
affecting a specific part of the body: their hands (9%) and
feet (16%) and, for 75%, their face or neck or other areas of
the body.
Persons with significant skin pathology diagnosed in the
survey examination were most likely to express concern
if the condition were psoriasis (69%), atopic dermatitis
(59%), contact dermatitis (47%), malignant tumors (34%),
and diseases of the sebaceous glands (35%).
Personal Burden
How then did these complaints translate to a personal
burden?
 A limitation of activity owing to the cutaneous diagnosis
was noted by 9% of persons having significant skin
pathology with one-third reporting the limitation to be
moderate to severe. Conditions involving the hands and
the feet are more likely to limit activity (15%) than those
of the feet (8%) or other parts of the body.
 A social handicap was cited by about one-third (33%)
with skin conditions, and of those socially handicapped
the percentage is substantially greater among women
(34%) than among men (25%).
 Disﬁgurement was a complaint of more than two-thirds
(68.1%) of those expressing concern and the complaint
was in turn rated by the dermatologists/examiners: 48%
were considered minimal, 20% were moderate, and
severe was highest among youths 12 to 17 y of age and
in older adults 55 to 74 y of age.
 Discomfort among examinees with skin complaints was
described as a burning sensation or pain by 22.8%, as
pruritus by 45.4%, and as physical limitation of motion
by 6%.
Figure 1
Prevalence rates for significant skin pathology among persons 1 to
74 y by age and sex: United States 1971 to 1974.
Figure 2
Prevalence rates for the seven leading types of skin pathology
among persons 1 to 74 y of age, by sex: United States 1971 to 1974.
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Nearly all (89%) of persons who considered their
condition a social handicap were also rated as disfigured
by the dermatologists/examiners. Agreement between the
examiner’s rating of disfigurement and the individual’s
reporting a handicap to employment or housework was
80%.
Adequacy of Dermatologic Care
Rating the adequacy of dermatologic care received by
persons with skin complaints, the examiners believed that
only 19% had received adequate care. Of the remaining
81% who had not, nearly all (94%), in the judgment of the
dermatologists/examiners, would improve with more expert
care.
In summary, HANES findings soundly refuted the widely
held opinion that skin disease was a trivial contributor to
illness, disability, and morbidity in the US population.
HANES findings greatly exceeded the intuitive estimates
of dermatologists in the magnitude of skin disease in the
United States 60 million, one-third of the US population with
skin pathology. Further, among the afflicted, more than
24 million coping with employment and social handicaps,
discomfort, and disfigurement, only 19% were receiving
care of adequate quality. HANES provided scientifically
derived and evidence-based data.
After HANES Almost 30 y have passed since HANES was
undertaken, and a HANES redux in all its comprehensive
and expensive finery is highly unlikely. Since the early
1970s, the US population has grown from 193 million to 281
million. Since 1971 to 1974, substantial changes have
occurred in the ethnic distribution of the US population,
primarily owing to immigration (U.S. Census Bureau, 2001).
For example, Hispanics are now the largest minority group,
exceeding 35 million. In two of our largest cities, Los
Angeles and New York, the ‘‘minorities’’ are becoming
majorities. Most of the population growth in the US has
occurred in cohorts of younger ages. Thus, the HANES-
documented prevalence rates in older persons (65 y and
older) have not been confounded by substantial new
additions and can be reliably extrapolated to the current
older population. For example, in the HANES 65- to 74-y
age group, the highest prevalence rates were for skin
tumors (18.4%), all malignant skin cancers (3.6%), basal cell
carcinoma (2%), and precancerous including actinic kera-
toses (8%). By the year 2000, the number of persons age 65
to 74 in the United States had increased by 5.6 million. In
2000, persons 75 y and older (a group not included in
HANES) numbered 16.6 million; the HANES data extra-
polated rate of malignant cancers for this group is 6%. The
total estimated numbers of additional persons with malig-
nant skin cancer is 204,000 in the 65- to 74-y age group and
996,000 for persons 75 y and older. The steep increases
reflect the aging of America: 35 million persons 65 y or
older, with 1 in 8 now more than 80 y of age.
Nevertheless, a repeat survey in 2003 would be likely
to discover new and additional dermatologic morbidity rela-
ted to the leading causes of illness and death in the US
population: cardiovascular disease (42%) and cancer (23%).
Immunosuppression, cardiovascular drugs, and chemo-
therapy have attendant dermatologic morbidity. Also, HANES
preceded the epidemic in the United States of HIV-AIDS.
Further, since HANES predated the ubiquitous implementation
of managed care, its estimates on access to dermatologic
care and the quality of care received can serve only as a 1971
to 1974 baseline.
In the past 30 y, US dermatology has made an enormous
advance in biomedical science and technology. To what
extent derived clinical benefits are accessible in the
dermatologic care of the US population, particularly to 40
to 60 million un- and underinsured, is a key question in
assessing the burden of skin disease.
I believe that the purpose of a new initiative on the
burden of skin disease, aside from updating the magnitude
of the problem and identifying the most burdened, is to
identify obstacles to mitigating the burden. In 1969 the
National Program for Dermatology sought ‘‘to conquer
disability due to skin disease through patient service,
education, and research’’ (American Academy of Dermatol-
ogy, 1969). In 2003, we have, within universal reach,
powerful communications technologies available that can
improve with great effect and efficiency the pattern and
quality of care of the system of delivering care to those who
bear the burden of skin disease.
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